|
FI20106031A0
|
|
Method of isolating cells and cell population isolated by the method
|
|
FI20105824A0
|
|
Use of blood group status IV
|
|
FI20105691A0
|
|
Device for simulation
|
|
FI20105660A0
|
|
Method for isolating cells and with the method isolated cell population
|
|
FI20105348A0
|
|
Use of a proteolytic enzyme
|
|
FI20105166A0
|
|
A method for detecting a differentiation state of a stem cell population
|
|
FI20096402A0
|
|
Use of blood group status II
|
|
FI20096400A0
|
|
Use of blood group status I
|
|
FI20096331A0
|
|
Using an Antibody
|
|
FI20095664A0
|
|
Cell Membrane Profile
|
|
FI20095517A0
|
|
Compounds and combinations
|
|
FI20095459A0
|
|
New Assay Methods
|
|
FI20095452A0
|
|
New Branch Sugar Analysis
|
|
FI20095418A0
|
|
Cryptic subpopulation
|
|
FI20080516A0
|
|
New acidic N-glycan structures
|
|
EP2166085A1
|
|
Divalent modified cells
|
|
US2010120142A1
|
|
Culture of human embryonic cells
|
|
FI20085724A0
|
|
Cell culture
|
|
US2010028913A1
|
|
Novel carbohydrate from human cells and methods for analysis and modification thereof
|
|
EP2108043A1
|
|
Novel methods and reagents directed to production of cells
|
